Talks focusing on the surgical and oncological management of kidney cancers and the adjuvant treatment of patients after surgery. This webinar will also provide an update on the most recent evidence for immunotherapy in patients with high risk and intermediate kidney cancer.
At the end of the webinar, learners will be able to:
- To understand the surgical and oncological management of intermediate and high risk kidney cancer.
- To understand the adjuvant treatment of patients after surgery with high risk kidney cancer.
- To update on the most recent evidence for immunotherapy in patients with intermediate and high risk kidney cancer.
